Treace Medical Concepts (TMCI) Cash & Current Investments (2020 - 2026)
Treace Medical Concepts' (TMCI) quarterly Cash & Current Investments came in at $51.9 million in Q1 2026, down 31.85% YoY from $76.1 million in Q1 2025, and up 7.21% on a QoQ basis from $48.4 million in Q4 2025.
Treace Medical Concepts (TMCI) Cash & Current Investments (2020 - 2026) Analysis & Trends
Treace Medical Concepts (TMCI) has 7 years of Cash & Current Investments data on file, last reported at $51.9 million in Q1 2026.
- Quarterly Cash & Current Investments fell 31.85% year-over-year to $51.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $51.9 million (down 31.85% YoY) and the FY2025 annual result came in at $48.4 million, down 36.09% from the prior year.
- Cash & Current Investments grew to $51.9 million in Q1 2026, from $48.4 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $170.7 million in Q1 2023 to a low of $48.4 million in Q4 2025.
- A 5-year average of $94.0 million and a median of $88.9 million in 2024 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2022 — Cash & Current Investments jumped 507.25% — and 2024, when it sank 38.57%.
- Tracing TMCI's Cash & Current Investments over 5 years: stood at $81.3 million in 2022, then jumped by 51.62% to $123.2 million in 2023, then slumped by 38.57% to $75.7 million in 2024, then sank by 36.09% to $48.4 million in 2025, then grew by 7.21% to $51.9 million in 2026.
- The last three Cash & Current Investments figures came in at $51.9 million (Q1 2026), $48.4 million (Q4 2025), and $57.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Treace Medical Concepts | 281.67 Mn | 236.05 Mn | 35.61 Mn | 45.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.62 Mn |
| Mar 31, 2026 | 51.85 Mn |
| Dec 31, 2025 | 48.37 Mn |
| Sep 30, 2025 | 57.42 Mn |
| Jun 30, 2025 | 69.29 Mn |
| Mar 31, 2025 | 76.09 Mn |
| Dec 31, 2024 | 75.68 Mn |
| Sep 30, 2024 | 82.80 Mn |
| Jun 30, 2024 | 95.05 Mn |
| Mar 31, 2024 | 110.01 Mn |
| Dec 31, 2023 | 123.20 Mn |
| Sep 30, 2023 | 122.16 Mn |
| Jun 30, 2023 | 139.48 Mn |
| Mar 31, 2023 | 170.66 Mn |
| Dec 31, 2022 | 81.25 Mn |
| Jun 30, 2022 | 101.53 Mn |
| Mar 31, 2022 | 98.48 Mn |
| Dec 31, 2021 | 105.83 Mn |
| Sep 30, 2021 | 109.46 Mn |
| Jun 30, 2021 | 119.62 Mn |